PWPS
CPRX

Pinnacle Wealth Planning Services’s Catalyst Pharmaceutical CPRX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.8K Buy
2,858
+92
+3% +$2.71K 0.01% 931
2026
Q1 		$68.5K Buy
2,766
+844
+44% +$20.1K 0.01% 1020
2025
Q4 		$44.9K Buy
+1,922
New +$42.8K ﹤0.01% 1266

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pinnacle Wealth Planning Services's CPRX Position: Q2 2026 in Review

Pinnacle Wealth Planning Services increased its Catalyst Pharmaceutical (CPRX) stake by 3.3% in Q2 2026, buying an estimated $2.71K and bringing the position to 2,858 shares worth $89.8K. The position accounts for 0.01% of the portfolio, ranked #931.

Pinnacle Wealth Planning Services first reported a position in CPRX in Q4 2025 and has held it in 3 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Pinnacle Wealth Planning Services held 2,858 shares of Catalyst Pharmaceutical worth $89.8K as of Q2 2026.
  • Pinnacle Wealth Planning Services bought 92 Catalyst Pharmaceutical shares in Q2 2026, an estimated $2.71K.
  • Catalyst Pharmaceutical made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #931 holding.
  • Pinnacle Wealth Planning Services first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.